Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Oliver Distler et al.|Annals of the Rheumatic Diseases|2014Cited by 432
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Dorota Krasowska, Oliver Distler et al.|Lara D. Veeken|2019Cited by 29
ABS0554 FEATURES OF ANTI-FIBRILLARIN POSITIVE SYSTEMIC SCLEROSIS PATIENTS AND ETHNIC DIFFERENCES: A EUROPEAN MULTICENTRIC COHORTR. D’Alessandro, Y. Allanore, Stefano Rodolfi et al.|Annals of the Rheumatic Diseases|2025Cited by 0